We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...
It's a blow to the SCD community, as Oxbryta (voxelotor) was the first drug to reach ... in 2022 of Global Blood Therapeutics (GBT), which brought Oxbryta to market in 2019. Pfizer said in a ...
Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...
Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results